Marina Biotech Reviews

Recommend to a friend
Approve of CEO
(no image)
J. Michael French
2 Ratings
  • Great company to work for!!

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Former Employee - Research Associate II in Bothell, WA
    Former Employee - Research Associate II in Bothell, WA
    Doesn't Recommend
    Negative Outlook
    Approves of CEO

    I worked at Marina Biotech part-time (More than a year)


    Great atmosphere, passionate scientists, I felt as if I was truly part of a team where I was valuable and appreciated.


    Poor management, just because you have a PhD does not necessarily dictate that you have sound management skills. Halo effect ultra-prevalent

Marina Biotech Interviews

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    Research Associate Interview

    Anonymous Interview Candidate
    Accepted Offer
    Positive Experience
    Easy Interview


    I applied through a recruiter. The process took 4+ weeks. I interviewed at Marina Biotech in September 2009.


    The interview was conducted by a panel of scientists who asked several questions about my research experience and future goals.

    Interview Questions

    • Why would you be a perfect fit for this company?   1 Answer

Marina Biotech Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Bothell, WA
Size 6 to 15 Employees
Founded Unknown
Type Company - Public
Industry Biotech & Pharmaceuticals
Revenue $1 to $5 million (USD) per year
Competitors Novartis, AstraZeneca, Alnylam

While it doesn't technically shoot the messenger, Marina Biotech (formerly called MDRNA) certainly works to silence it. The drug discovery company is developing treatments using gene silencing approaches such as RNA interference (RNAi) and messenger RNA (mRNA) blocking. It conducts clinical and preclinical tests on RNAi treatments for a variety of cancers. Marina Biotech has built up its holdings by licensing peptides with potential RNAi therapy applications from numerous pharmaceutical companies and universities including the University of Michigan. It also has an ... More

Work at Marina Biotech? Share Your Experiences

Marina Biotech

Click to Rate